Skip to main content
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review articles by experts on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery.

Publisher: Bentham Science Publishers

Volume 3, Number 3, 2009

Articles

Recent Efforts to Develop Imaging Methods and β -Cell-Specific Contrast Agents for Non-Invasive in vivo Assessment of β-Cell Mass
pp. 157-161(5)
Authors: Schneider, Stephan; Virostko, John; Reimann, Astrid; Powers, Alvin C.

Favourites:
ADD

Obesity and Asthma
pp. 162-172(11)
Authors: Hauber, Hans-Peter; Wegmann, Michael

Favourites:
ADD

Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders
pp. 173-178(6)
Authors: Davis, Jeremy E.; Hou, Yuqing; Meyers, Cal Y.; Banz, William J.

Favourites:
ADD

Recent Patents on Oral Vaccine Design
pp. 179-193(15)
Authors: Mangal, Sharad; Garg, Neeraj K.; Mounavya, Aligeti; Sahu, Tejram; Tyagi, Rajeev K.

Favourites:
ADD

Perspectives in Therapeutic Innovation in Ocular Surface Disorders and Dry Eye Syndrome
pp. 194-199(6)
Authors: Cade-Jorge, Fabiano; Jorge, Italo C.; Kusabara, Alessandra A.; Rocha, Eduardo M.

Favourites:
ADD

Liraglutide-A Novel GLP-1 Analogue
pp. 200-204(5)
Authors: Kalra, Sanjay; Kalra, Bharti; Sharma, Amit

Favourites:
ADD

Update on ICOS: A Possible Target for Turning-Off Autoimmunity
pp. 205-213(9)
Author: Sakthivel, Priya

Favourites:
ADD

Targeting Cancer Stem Cells: How to Switch Off Immortality
pp. 225-232(8)
Author: Prado, Ana M.

Favourites:
ADD

Patent Selections
pp. 233-236(4)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content